BioSante Sued Again Over Female Libido Drug Disappointment
BioSante Pharmaceuticals was hit with a shareholder derivative suit in Illinois state court Wednesday alleging company directors overhyped the effectiveness and market potential of its LibiGel drug that was meant to...To view the full article, register now.
Already a subscriber? Click here to view full article